TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Helicobacter pylori
Research by D.Y. Graham and colleagues in helicobacter pylori provides new insights
April 14th, 2009
"Annually hundreds if not thousands of patients fail empiric H pylori eradication therapy. Failure occurs in part because routine post treatment testing, which provides an early warning of increasing antibiotic resistance, is not universally done and physicians are generally unaware that cure rates with legacy triple therapy (a proton-pump inhibitor, amoxicillin, and clarithromycin) in most places has fallen below 80%," scientists in the United States report. "We propose first, institution of routine post eradication testing and second, abandonment of the ''better than another therapy'' approach to separating acceptable from unacceptable therapies. Instead, we propose...
Source: TB & Outbreaks Week (2009-04-14)
|
